PURPOSE: To identify additional mutations in the ABCR gene and describe the
clinical features of four affected siblings with autosomal recessive Starg
ardt disease.
METHODS: A cohort of eight siblings was identified for study. Four of these
individuals were diagnosed with Stargardt disease based on clinical evalua
tion and fluorescein angiography, Blood samples were obtained from seven of
eight siblings, including all those affected. All 50 exons of the ABCR gen
e were analyzed by single stranded confirmation polymorphism analysis, foll
owed by direct sequencing of observed variants, to identify mutations in th
e ABCR gene.
RESULTS: We identified a previously unreported kindred of eight siblings, f
our of whom had mutations in both of their ABCR alleles, A previously descr
ibed G-to-C transversion of nucleotide 2588, predicting a Gly863Ala amino a
cid substitution, and a novel G-to A transition of nucleotide 161, resultin
g in a Cys54Tyr substitution, were identified, These mutations co-segregate
d with the affected members of this family. Three of the siblings demonstra
ted clinical features characteristic of classic Stargardt disease, with bil
ateral regions of macular atrophy associated with yellow white "flavimacula
tus" flecks in the posterior pole at the level of the retinal pigment epith
elium. The fourth affected sibling showed features of early Stargardt disea
se, with a beaten-bronze appearance to both maculas, as well as perimacular
flecks. In all four affected patients, fluorescein angiography showed a ch
aracteristic peripheral dark choroid,
CONCLUSIONS: We have identified both a previously described and a novel mut
ation in the ABCR gene in four patients with autosomal recessive Stargardt
disease. In depth knowledge of the ABCR mutation spectrum in patients with
Stargardt disease will provide for more efficient screening and may provide
potential therapies for Stargardt disease and other retinal diseases. (C)
1999 by Elsevier Science Inc, All rights reserved.